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lebih sedikit terjadi dibanding varises esofagus, namun tingkat morbiditas dan mortalitasnya tinggi. Berikut 
la?oran kasus ?erdarahan varises gaster non?sirosis. ?aki?laki ?? tahun mengalami hematemesis melena dengan 
anemia. ?etelah stabilisasi hemodinamik dida?atkan varises gaster esofagus ti?e ????? ? dan diberikan tera?i 
de?nitif endosko?i obturasi dengan injeksi intravarises histoa?ryl terdilusi. ?etelah tindakan dida?atkan efek 
samping ringan dan sementara serta tidak didapatkan perdarahan ulang hingga bulan ke7.
Kata kunci: varises gaster, histoa?ryl, injeksi perekat
INTRODUCTION
Upper gastrointestinal bleeding (UGB) is 
distinguished by variceal and non-variceal bleeding. 
Commonly reported causes of UGB are ulcers (31-
67%), varices (6-39%), gastroduodenal erosion (2-
?????? ?????????? ???????? ???? ???????????? ????????
(5-14% ).1,2,3 UGB varices caused by rupture of varices 
due to portal hypertension (PHT) related to cirrhosis 
and non-cirrhosis varices which occur in the esophagus 
and gastric. Management is intended to reduce the 
??????????? ???????????????? ???? ????????????????????
variceal bleeding.
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In non-cirrhotic portal hypertension (NCPHT), 
the rate of gastric varices is around 20%, with gastric 
variceal bleeding occurring only in 25% of patients, but 
????????????????????????????????????????????????????????
bleeding, high rates of rebleeding, and the need for 
blood transfusion more massive.4,5,6,7 Gastric varices 
?????????????????????????????????????????????????? ????
profuse.8
Fast and adequate therapy is urgently needed. 
Endoscopic therapy is done to stop variceal bleeding 
and as primary and secondary prophylaxis. If 
endoscopic therapy failed, radiologic intervention 
???????????????????????????????????????????????????????
therapy is injection of cyanoacrylate in varices 
with the help of endoscopy as well as endoscopic 
ultrasonography (EUS).5 We present the case of 
non-cirrhotic portal hypertension patient with gastric 
varices which have bleeding.
CASE ILLUSTRATION
A 19-year-old man, with job as porter, came 
to the emergency room of Dr. Soetomo Hospital 
with complaints of defecation and black vomiting. 
Complaints were felt 1 day ago. Black stools petis-
like 2 times, about half aqua glass each time he 
defecated. Black vomit 2 times, approximately 2 
glasses of aqua each vomit, mixed with food. He felt 
weak and pounding. Seven days ago, patients have 
the same complaint. He had history of analgesic drug 
consumption 4 days previously.
On physical examination, there was severe illness, 
general condition looked weak, GCS 456. Blood 
pressure 110/60 mmHg, tachycardia (pulse 128 x/
minute, regular rhythm, enough strength), conjunctival 
anemic, nasogastric tube (NGT) with no hematin 
production. Lien Schnuffer 1 Hacket 1, liver is not 
palpable, no ascites. The extremities are warm, dry, 
and red. There is no edema, nor palmar erythema and 
petechiae. From digital rectal examination, it was 
obtained grade 4 internal hemorrhoids, with black 
blood on the medical glove.
Laboratory tests found Hemoglobin (Hb) 5.3 g/
dL, mean corpuscular volume (MCV) 101.6 fL, 
mean corpuscular hemoglobin (MCH) 33.7 pg, 
aspartate aminotransferase (AST) 43 U/L, alanine 
aminotransferase (ALT) 29 U/L, albumin 4.0 g/dL, 
total protein 7.1 g/dL, direct bilirubin 0.56 mg/dL, total 
bilirubin 1.3 mg/dL, partial thromboplastin time (PPT) 
12.5 seconds (control 11.7 seconds), activated partial 
thromboplastin time (APTT) 26.4 seconds (control 
24.5 seconds), Hepatitis B surface antigen (HBsAg) 
????????????? ??? ???????? ??? ?????????? ????????????
there are no visible liver parenchymal abnormalities, 
???????????????????????????????????????????????????
portal veins.
Diagnosis of the patient is hematemesis melena ec 
suspect of variceal bleeding in non-variceal bleeding 
with anemia. Patient was planned for endoscopy, 
protein electrophoresis, hepatitis C virus markers, and 
?????????????????????? ????????????? ?????????? ?????????
???? ????????????? ????????? ??? ?????? ????????????
Lansoprazole bolus injection of 2 ampoules continued 
with continuously 6 mg/hr, transfusion of packed red 
blood cells (PRC) 1 colf/day until Hb > 8 gr/dL. Vital 
signs was also monitored.
Figure 1. Endoscopic image of GOV 2 gastric varices
The serum protein electrophoresis result showed 
no abnormalities. Fibroscan obtained 11.2 Kpa. 
Non-reactive anti-HCV was found. Gastroscopy was 
done with result of grade 2 esophageal varices and 
fundus variance (GOV 2) accompanied by congestive 
gastropathy. Patient was given histoacryl intra-varices 
injection in fundal varices.
Post-injection, patient was evaluated and there were 
no complaints of chest pain, tightness, or bleeding 
Figure 2. Endoscopic image of post injection of hystoacryl 
intra-varises
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found. Patient was given additional therapy in the 
form of oral Propranolol 3 x 10 mg and Lactulose 1 
x 15 mL, the patient was treated as outpatient. One 
week later, when repeated gastroscopy evaluation 
was done, esophageal varices and fundal varices were 
reduced. During follow up to the patient in 1 month 
and 7 months post-procedure, no complaint was found.
DISCUSSION
Upper gastrointestinal bleeding related to varices is 
caused by rupture of varices in PHT both in cirrhosis 
and non-cirrhosis. The diagnostic criteria for non-
?????????? ???????????????????? ???? ?????? ???????????
for the Study of the Liver (APASL) are moderate to 
severe splenomegaly; portal hypertension, varices, 
and/or collateral; spleno-portal axis and patent hepatic 
vein on Doppler ultrasound; normal or near normal 
liver function tests; normal or near normal hepatic 
venous pressure gradient; liver histology without 
signs of cirrhosis or liver abnormalities. In addition, 
there are additional criteria in the form of no sign of 
liver chronicity; no decompensation after variceal 
bleeding except transient transient ascites; no hepatitis 
B or C virus markers; there was no known etiology of 
portal vein with peripheral thinning and hyperechoic 
periportal area.9
In PHT without signs of hepatic parenchymal 
dysfunction, there can be found non-cirrhotic portal 
???????? ????????????????????????????????????????????
and extra hepatic portal vein obstruction. Biopsy 
confirmation is needed to exclude the possibility 
of hepatic cirrhosis, which can now be replaced by 
a fibroscan examination.10,11 From the anamnesis 
of patients, history of vomiting of blood and black 
stool without swelling in the stomach or legs can be 
found. From the physical examination splenomegaly 
without ascites and palmar erythema can be found. 
Ultrasound examination revealed splenomegaly with 
??????? ?????????????? ??????????????????????????????
reactive HBsAg, non-reactive Anti-HCV, and unknown 
??????????????????????????? ????????????????????????????
be interpreted.
According to APASL, around 10-30% of all cases 
of variceal bleeding are caused by NCPF. It is often 
occurs in young men in the third to fourth decades 
and low socioeconomic groups.9 This is in accordance 
with the patient’s condition, a 19-year-old male with 
job as a porter.
??????????????????????????????????????????????? ???
Sarin is distinguished by location and esophageal 
involvement. Gastroesophageal type 1 varices (GOV1) 
involves the esophagus that extends to gastric minor 
curvatura, 2-5 cm below the gastroesophageal border. 
Gastroesophageal type 2 varices (GOV2) involves the 
esophagus until the gastric fundus. Isolated gastric 
varices type 1 (IGV1) does not involve the esophagus, 
varices in the gastric fundus. Isolated gastric varices 2 
(IGV2) ectopic varices in the antrum, body and around 
the pylorus. The prevalence of GOV1 is 75%, GOV2 
is 21%, IGV1 is less than 2%, and IGV2 is 4%. The 
incidence of variceal bleeding was highest in GOV2 
and IGV2 types. In addition, gastric varices are divided 
into primary (without a history of endoscopic therapy) 
and secondary (with a history of endoscopic therapy).5,6 
In the patient, it was found GOV2 and primary varices. 
Gastric varices include submucosa under the gastric 
mucosa and the muscularis layer, relatively thicker 
?????????????????????????????????????????????????????
??? ???????? ???? ????????? ??? ???????????? ?????????????
ruggae. Gastric varies get vascularization from the left 
gastric vein, gastrorenal shunt, posterior gastric vein, 
???????????????????????????????????????????????????????
control.5,7,12,13
Management of therapy for gastric varices patients 
includes intensive care, hemodynamic stabilization, 
treating acute bleeding, preventing recurrent bleeding, 
and primary and secondary prophylaxis. Hemodynamic 
stabilization was performed in patient with crystalloid 
??????????????????????????????????????????????????
??????????????????????????????????????????????? ???????
of somatostatin or vasopressin can still be used in the 
case of GOV1 which treated as esophageal varices. 
The use of beta blockers can reduce the incidence 
of recurrent bleeding. Patients get propranolol with 
the aim of reducing portal vein pressure to prevent 
rebleeding. The use of balloon tamponade, Linton-
Nachlas tube, is as an intermediary therapy towards 
????????????????????????????????????? ??????????????
for 24 hours in massive bleeding conditions, unstable 
hemodynamics, and blood-covered endoscopic visual 
?????5,6,13
Definitive therapy of gastric varices includes 
endoscopic therapy, radiological intervention therapy, 
or surgical therapy. Endoscopic therapy is divided 
into endoscopic sclerotherapy (EVS), endoscopic 
obturation (EVO), and endoscopic ligation (EVL). EVS 
uses sclerosic materials such as oleic ethanolamine, 
pure alcohol, or tetradesil sulfate which causes 
endothelial damage, thrombosis and varices sclerosis. 
EVS has a high rate of rebleeding so it is not used 
????????????? ???????? ??? ???????? ????????? ??????????????
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thrombin injection uses both bovine and human 
(more widely used because of fewer side effects than 
?????????????????? ?????????? ????????? ?????????? ???
?????????????????????????????????????????????????????????
variceal bleeding stops. Radiological intervention 
therapy is differentiated into transjugular intrahepatic 
portosystemic shunt (TIPS), ballon-occluded retrograde 
transvenous obliteration (B-RTO), and ballon-occluded 
endoscopic injection sclerotheraphy. Radiological 
interventions are performed when endoscopic therapy 
has been given but refractory bleeding occurs. If the 
radiological intervention is still not able to stop variceal 
bleeding, surgery can be taken both selectively and 
???????????????????????????????????????????????5,6,13,14 
In the patient, definitive therapy selected is the 
obturation endoscopic therapy of GOV2-related.
EVO therapy uses n-butyl-2-cyanoacrylate 
(histoacryl) injection. Cyanoacrylate is a water-soluble 
monomer which undergoes rapid polymerization in 
the presence of ionic substances such as those present 
in blood. Cyanoacrylate is known as an agent of 
hemostatics. When cyanoacrylate mixes with blood 
it will solidify in 20 seconds and change varices into 
thrombosis, which then bleeding stop. This procedure 
is carried out by endoscopy or EUS. Lipiodol is an 
oil-soluble contrast agent that can slow the occurrence 
of polymerization so that cyanoacrylate does not 
experience compaction too quickly when mixed with 
blood. In addition, the use of lipiodol has a contrast 
?????????????????????????????????????????????????????
Evaluate of thrombosis after injection is done by 
pressing the density of varices that have been injected 
with the end of the endoscope. EVO is a therapeutic 
choice for gastric varices which experience acute 
bleeding as well as secondary prophylaxis. 90% of cases 
undergo hemostasis. EVS can undergo hemostasis in 
62% of cases and EVL in 40% of cases. The incidence 
of rebleeding in histoacryl injection reaches 15% 
while the other modalities reach 22-25%. Repetition 
of cyanoacrylate injection can be done in 4 weeks. 
Repeated bleeding events were evaluated in 1 month, 
???????????????????????????????????????????????????????
post-treatment.5,6,7,15,16 Injections 1-3 times is needed 
to achieve varices obliteration.8,17,18 In the patient, 1.2 
mL histoacryl and lipidol (0.5 mL cyanoacrylate: 0.7 
mL lipiodol) were intra-varises injected through an 
endoscopic guide. Evaluation was carried out 1 week 
post-procedure, the size of varices was reduced so 
that repeated histoacryl injection was not needed as 
secondary prophylaxis. Evaluation of endoscopy was 
carried out again 2 months post-procedure with the 
size of the varices shrinking and reinjection will be 
Figure 5. Gastric varices management algorithm12
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carried out as secondary prophylaxis, but because the 
ingredients were not in the pharmacy, the procedure 
was delayed. Endoscopic evaluation in the 7th month 
post-procedure showed that the size of varices was 
reduced and there were no bleeding complaints.
Side effects of procedure which can occur are 
fever (33%) and temporary and mild abdominal pain 
(17%). In patients, chest and abdominal pain occured 
post injection histoacryl. Complaints improved with 
anlagetic administration. Complaints occur mildly and 
temporarily. Occasional side effects include emboli 
(0.7%) in cerebral, pulmonary, and splenic. In addition 
complications can also occur in the form of rebleeding 
(less than 15%), gastric ulceration (0.1%), visceral 
???????????????????????????????????????5,6,13,17,19,20,21
In conclusion, case of gastric varices have 
been reported in patient with non-cirrhotic portal 
hypertension who experience acute bleeding. The 
definitive therapy used is EVO with intra-varises 
injection with histoacryl with an endoscopic guide. 
Patients experienced mild and transient side effects of 
chest and abdominal pain which can be treated with 
analgesics. Endoscopic evaluation is carried out at 1 
week, 2 months, and 7 months post-procedure. The 
size of varices was found to be smaller and there was 
no rebleeding.
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